Variable | SN-APS (n=67) | SP-APS (n=87) | p value |
---|---|---|---|
Venous thrombosis | 27 (40.2%) | 40 (45.9%) | 0.51 |
DVT | 21 (31.4%) | 27 (31.0%) | 0.96 |
Recurrent DVT | 8 (38.0%) | 10 (37.0%) | 0.94 |
PE | 16 (23.8%) | 25 (28.7%) | 0.58 |
Recurrent PE | 5 (31.5%) | 2 (8.0%) | 0.08 |
Arterial thrombosis | 23 (34.3%) | 30 (34.4%) | 0.98 |
Stroke | 10 (14.9%) | 15 (17.2%) | 0.82 |
Recurrent stroke | 3 (30%) | 2 (13.3%) | 0.35 |
Transient ischaemic attack (TIA) | 8 (11.9%) | 9 (10.3%) | 0.79 |
Recurrent TIA | 1 (12.5%) | 3 (33.3%) | 0.57 |
Coronary artery disease | 6 (8.9%) | 4 (4.6%) | 0.33 |
Pregnancy morbidity | 60/64 (93.7%) | 57/69 (82.6%) | 0.06 |
<10th week spontaneous abortion | 43/64 (67.1%) | 36/69 (52.1%) | 0.11 |
>10th week fetal loss | 40/64 (62.5%) | 41/69 (59.4%) | 0.72 |
Prematurity <34th week | 18/64 (28.1%) | 15/69 (21.7%) | 0.42 |
Pre-eclampsia | 18/64 (28.1%) | 16/69 (23.1%) | 0.55 |
APS, antiphospholipid syndrome; DVT, deep vein thrombosis; PE, pulmonary embolism; SN-APS, the so-called seronegative APS; SP-APS, seropositive APS.